This report focuses on the Metagenomics Market Size, Revenue, Share, status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Metagenomics development in North Americas, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America (SA).
According to a new market research study titled Metagenomics Market to 2027 – Global Analysis and Forecasts by Product, Application, and Geography. The global metagenomics market is expected to reach US$ 314.3 Mn in 2027 from US$ 165.8 in 2018. The market is estimated to grow with a CAGR of 7.7% from 2018-2027. The growth of the market is driven by the factors such as increasing venture capital investments, advantages of metagenomics in biotechnology and industrial application of metagenomics likely to have a positive impact on the growth of the market in the coming years. However, high capital cost of metagenomics is anticipated to restrain the market growth.
The major players operating in the metagenomics market include Merck KGaA, Thermo Fisher Scientific Inc., Agilent Technologies, Qiagen, Bio-Rad Laboratories, Inc., Perkinelmer Inc., and Illumina Inc., f Hoffman-La Roche Ltd., Oxford Nanopore Technologies Ltd., Pacific Bioscience of California, Inc., among others. For instance, in October 2018, Pacific Biosciences of California, Inc. announced it has produced the most contiguous diploid human genome assembly of a single individual to date, representing the nearly complete DNA sequence from all 46 chromosomes inherited from both parents.
Get Sample PDF Brochure of this research report at https://www.theinsightpartners.com/sample/TIPRE00002997/
The clinical diagnostics segment held the major market share among the application segment in the global metagenomics market. The market players are incorporating organic growth strategies such as introduction of new products into the market to sustain their global position in the highly competitive global metagenomics market. For instance, in August 2018, Agilent Technologies Inc. announced launch of the new version of its chromatography data system that will help to export lab files in the Allotrope Data Format (ADF), an emerging standard developed by a consortium of pharmaceutical companies.
The extensive research for the microbial studies are being conducted to study the genetic make-up of the microorganisms. The collection of the microbial sample collected from the environmental resources owes the huge diversity in their genes. The study have helped to discover antibiotics and are expected to assist more in the drug discovery in the coming future. The current trend of the molecular-based approaches has enabled the field of the metagenomics to study the uncultured microorganisms. The metagenomics has also helped in the huge way for the clinical diagnostics and the clinical diagnostics is the current trend going on cross the world. Also the extensive research is been going-on currently for the environmental sectors. Also the metagenomics have potential to discover products for the biotechnology, agriculture biotechnology, food technology and others.
The potential of the metagenomics in the pharmaceuticals owe to the large hopes for growth opportunities for the market players. Also the novel innovations from the market players are likely to discover the solutions for the chronic infectious diseases. The initial cost of the primary set up for the metagenomics is very high, however, the technological advancement and the efforts by the market leader such as Illumina Inc., Pacific Bioscience of California Inc., among the others are likely to meet this challenge. These market players are aggressively working to provide cost effective solutions for the metagenomics studies. The healthcare industry is likely to experience the positive outcomes in the coming future.
Place a Purchase Order at https://www.theinsightpartners.com/buy/TIPRE00002997/
The metagenomics based on application is segmented into clinical diagnostics, drug discovery, and others. Clinical Diagnostics segment is anticipated to grow at a CAGR of 7.2% during the forecast period. The metagenomics offers prodigious potential for the identification of uncultured microorganism that can be used to detect and diagnose infectious diseases and the genetic properties of the microorganism. Therefore, the segment held the largest market share among the application segment in the metagenomics market and is likely to dominate the market in coming forecast period.
The report segments the global metagenomics market as follows:
Global Metagenomics Market – By Product
• Instruments & Software
Global Metagenomics Market – By Application
• Clinical Diagnostics
• Drug Discovery
Global Metagenomics Market – By Geography
• North America
• Asia Pacific (APAC)
• Middle East & Africa (MEA)
• South & Central America (SCAM)
Key Benefits of Buying this Research Study:
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Metagenomics market
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the Metagenomics market, thereby allowing players across the value chain to develop effective long term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution
- Examine the political, economic, social and technology impact of the five regions namely: North America, Europe, Asia Pacific, Middle East & Africa and South America.
Company Name: The Insight Partners
Contact Person: Sam J
Email: Send Email